Krauth Medical: Redefining European Hospital Supply
Executive SummaryUnlike their logistics-driven counterparts in the US, European hospital supply distributors have stressed their role as exclusive sales agents for selected manufacturers. But in Germany, cost pressures are forcing hospitals to look at process as much as product, leading suppliers like Krauth into an array of service-oriented, asset management-based businesses.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.